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The rapidly expanding field of stem cell research focuses on 
defining the required cell type for the right task in regenerative 
therapy. Thus, the foremost objective for successful cell replace-
ment treatments is to understand which cell type e.g. stem cells 
or early progenitor cells versus mature and functional deriva-
tives of these stem/progenitors are more suitable to achieve the 
desired long-term treatment benefit and ultimately tissue repair/ 
regeneration. Several stem cell sources including embryonic, 
umbilical cord blood-derived, adult or tissue-residing and induced 
pluripotent stem cells have been evaluated in several settings dis-
playing both advantages and disadvantages depending on the cell 
type end experimental setting used. Research in the last decade 
indicated that another fetal stem cell source, the amniotic fluid-
derived stem cell (AFS) is gaining importance and yields prom-
ising results for regenerative applications. This research field is 
rapidly expanding since the discovery of fetal cells in amniotic 
fluid more than 50 years ago and that amniotic fluid is not just 
a liquid protective barrier for the developing fetus but is also a 
reservoir of many important substances ensuring fetal well being 
and maturation during gestation. Alongside these discoveries the 
focus shifted to the cells floating in amniotic fluid. Amniotic 
fluid contains a heterogeneous mixture of cells originating from 
the fetus or the fetal membrane which have been described to be 
composed of already committed and differentiated amniocytes 
and of cells displaying stem cell potential similar to mesenchymal 
stem cells. However, the feasibility and efficacy of these amniotic 
fluid-derived stem cells (AFS) in regenerative medicine applica-
tions is hampered by the outcome discrepancies amongst reports. 
This might be due to the observation that the potency of AFS is 
based on the employed isolation and enrichment approach. The 
review by Mara Cananzi and Paolo De Coppi (p. 77) summarizes 
general information about the isolation, characterization and 
potency of AFS with the focus on AFS selected by the expres-
sion of the cell surface marker CD117. These CD117-positive 
AFS exhibit the most promising stem cell capacity of all reported 
AF-derived cells so far and have been employed in several preclin-
ical studies ranging from various tissue compartments and dis-
ease models. The outcome of these studies supported the notion 
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that AFS are indeed a suitable cellular source for tissue repair pro-
cesses by improving the endogenous tissue repair through secre-
tion of soluble factors or by providing progeny capable to actively 
participate in tissue repair. 
However, AFS cannot only be considered for in vivo tis-
sue repair processes but also to supply progeny for the in vitro 
engineering of tissue replacement parts. The review by Shaun 
Kunisaki (p. 99) gives an insightful overview on the treatment 
options for congenital anomalies with the emphasis on AFS for 
the in vitro tissue engineering of replacement parts. The main 
advantage of AFS is that they can be applied in an autologous set-
ting. Amniotic fluid can be collected during amniocentesis and 
AF-derived cells can be isolated and expanded alongside gesta-
tion. The advances in generating replacement parts from AFS 
allow the repair of congenital anomalies either still in utero or 
directly after birth with living grafts. It is assumed that theses 
grafts possess the intrinsic capacity to grow with the child thus 
reducing the need of repeated surgery to maintain the repair 
effect during postnatal development. 
In general, amniocentesis is performed if a genetic defect of 
the unborn child is suspected. Thus the obtained AFS reflect 
the health status of the unborn child and can be used to inves-
tigate factors controlling cell fate. The review by Margit Rosner, 
Katharina Schipany, Bharanidharan Shanmugasundaram, Gert 
Lubec, Oliver Brandau and Markus Hengstschläger (p. 96) sum-
marizes the data available on AFS to investigate cellular behav-
ior and the role of signaling pathways. The authors focus on the 
mTOR pathway, which is known to be involved in many cellular 
processes including cell fate specification. They introduce the 
notion that AFS from different donors could be used to mimic 
disease modeling or for deciphering relevant signaling path-
ways for stem cell homeostasis by applying a gene manipulation 
approach. Results from these efforts should advance our under-
standing of stem cell definition and differentiation potential   
in vitro and in vivo. Taken together these reviews highlight the 
broad versatility of AF-derived stem cells to address basic scien-
tific principles and their potential for advancing the understand-
ing of tissue regeneration.